Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin + Metformin, ATC A10BD15 für die Zeit 01.10.2024 - 30.09.2026
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- AstraZeneca GmbH
- Contract value
- no value published
- Bids received
- 2
- Published
- 30 Sept 2026
- Awarded
- 1 Oct 2024
- Contract start
- 1 Oct 2024
- Contract end
- 3 Oct 2025estimated
- Region
- Hamburg